Blog

Theses, frameworks, and analysis from the XO Medtech team — on manufacturing, strategy, and AI in the device industry.

Claude for Manufacturing: How Medical Device CDMOs and Contract Manufacturers Can Use It
AIClaude for ManufacturingCDMOMedtech Manufacturing

Claude for Manufacturing: How Medical Device CDMOs and Contract Manufacturers Can Use It

How medical device contract manufacturers, CDMOs and suppliers can use Anthropic's new Claude for Manufacturing: draft quotes and NCRs, with human review.

XO Medtech·Nov 13, 2026
Medical device adverse events: what 5 years of FDA MAUDE data says about 16 of the largest OEMs
AnalysisMedtech ManufacturingFDA Data

Medical device adverse events: what 5 years of FDA MAUDE data says about 16 of the largest OEMs

Sixteen of the largest device makers are tied to 4.8 million FDA adverse event reports in five years. Each file has its own failure signature, and it is legible.

XO Medtech·Sep 9, 2026
Q3 SBIR/STTR medical device awards: 67 grants, $57.9M, and a six-month hole
AnalysisMedtech FundingMarket Data

Q3 SBIR/STTR medical device awards: 67 grants, $57.9M, and a six-month hole

NIH issued 67 SBIR/STTR medical device awards worth $57.9M in Q3 2026 through August 11, following two straight quarters with zero awards. Full breakdown.

XO Medtech·Aug 11, 2026
KKR's $5.7B blockbuster acquisition of Integer: the largest CDMO take-private deal ever
AnalysisMedtech M&ACDMO

KKR's $5.7B blockbuster acquisition of Integer: the largest CDMO take-private deal ever

KKR is acquiring Integer for $5.7B, the largest public take-private of a medtech CDMO on record. The deal, both companies, and what private equity does next.

XO Medtech·Aug 4, 2026
The Medtech Supplier Roll-Up: 276 Transactions Since 2020
Market ReportMedtech ManufacturingM&A

The Medtech Supplier Roll-Up: 276 Transactions Since 2020

A data review of 276 medtech supplier transactions since 2020: who is transacting, what is being bought, and what the deal count does and does not establish.

XO Medtech·Jul 28, 2026
Q2 2026 medtech earnings are a contract-manufacturing demand map
SignalMedtech ManufacturingEarnings Signals

Q2 2026 medtech earnings are a contract-manufacturing demand map

Abbott, J&J and Intuitive just reported. Skip the stock moves — the real signal is new FDA filings, U.S. capacity build-outs, and supplier realignment.

XO Medtech·Jul 21, 2026
Dual-energy ablation: the second wave of PFA adoption
AnalysisCardiac AblationMedtech Trends

Dual-energy ablation: the second wave of PFA adoption

Cardiac ablation switched from thermal to pulsed field in under two years. Dual-energy RF+PFA catheters are the second wave. Here's the adoption data and the forecast.

XO Medtech·Jul 15, 2026
The CDMO who cracks carbon fiber catheter reinforcement will dominate
ThesisMedtech Manufacturing

The CDMO who cracks carbon fiber catheter reinforcement will dominate

Sinopec just put T1000-grade carbon fiber into mass production. The material is here. The manufacturing know-how is not. That gap is the whole opportunity.

XO Medtech·Jul 9, 2026